Pfizer Inc (PFE)
7 Mar 2014
|Market Cap (Mil.):||$206,998.30|
|Shares Outstanding (Mil.):||6,382.92|
March 6 - Pfizer Inc said on Thursday it was recalling two lots of its Effexor XR antidepressant and another lot of its generic version of the drug after a pharmacist reported finding one capsule of a different medicine in a bottle of Effexor.
(Adds details on standard Pneumovax vaccine, updates share price, final two paragraphs)
- Pfizer Inc said on Monday that Prevnar 13, its blockbuster vaccine against childhood infections, prevented pneumonia outside of hospitals in people age 65 and older, in one of the largest drug trials ever conducted.
Feb 24 - Pfizer Inc said on Monday that Prevenar 13, a drug widely used to prevent infection in children, showed in a study of 85,000 people that it prevented community-acquired pneumonia in individuals age 65 and older.
SYDNEY - Australia's competition regulator said on Thursday it was taking legal action against the local division of Pfizer Inc over the way it marketed its cholesterol-lowering drug Lipitor to pharmacies.
SYDNEY, Feb 13 - Australia's competition regulator said on Thursday it was taking legal action against the local division of Pfizer Inc over the way it marketed its cholesterol-lowering drug Lipitor to pharmacies.
- An advisory panel to the U.S. Food and Drug Administration said on Tuesday that available evidence does not prove that the painkiller naproxen, sold under the brand names Aleve and Naprosyn, carries a lower cardiac risk than rival products.
Feb 11 - An advisory panel to the U.S. Food and Drug Administration said on Tuesday that available evidence does not prove that the painkiller naproxen, sold under the brand names Aleve and Naprosyn, carries a lower cardiac risk than rival products.
WASHINGTON, Feb 6 - Pfizer Inc, the world's largest drugmaker, has beaten back generic competition for the pain medicine Lyrica, its biggest product, with a U.S. appeals court ruling that competing generic products would infringe on the company's patents.
(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks rose on Tuesday, underpinned by a slew of sturdy corporate results, as the market regained its footing following its largest selloff in months a day earlier. The Dow Jones industrial average was up 0.67 percent at 15,476.2, the S&P 500 was up 0.95 percent at 1,758.4 and the Nasdaq Compo
|The Procter & Gamble Company (PG.N)||$78.38||+0.32|
|Johnson & Johnson (JNJ.N)||$93.32||+0.43|
|Novartis AG (NOVN.VX)||CHF72.85||-1.45|
|Merck & Co., Inc. (MRK.N)||$57.47||+0.21|
|Roche Holding Ltd. (ROG.VX)||CHF258.90||-4.30|
|Abbott Laboratories (ABT.N)||$39.57||-0.16|
|Bayer AG (BAYGn.DE)||€96.71||-2.88|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€74.90||-0.71|
|AstraZeneca plc (AZN.L)||3,985.00p||-26.00|
Earnings vs. Estimates
Analyst Research Reports
Provider: Wright Reports
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: Pechala's Reports
Pfizer Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.